These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Histone onco-modifications. Füllgrabe J; Kavanagh E; Joseph B Oncogene; 2011 Aug; 30(31):3391-403. PubMed ID: 21516126 [TBL] [Abstract][Full Text] [Related]
3. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets. Herranz M; Esteller M Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications. Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893 [TBL] [Abstract][Full Text] [Related]
5. Epigenetics and MicroRNAs in Cancer. Ramassone A; Pagotto S; Veronese A; Visone R Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401683 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic alterations in cancer. Ilango S; Paital B; Jayachandran P; Padma PR; Nirmaladevi R Front Biosci (Landmark Ed); 2020 Mar; 25(6):1058-1109. PubMed ID: 32114424 [TBL] [Abstract][Full Text] [Related]
10. Altered primary chromatin structures and their implications in cancer development. Ferraro A Cell Oncol (Dordr); 2016 Jun; 39(3):195-210. PubMed ID: 27007278 [TBL] [Abstract][Full Text] [Related]
11. Interplay between different epigenetic modifications and mechanisms. Murr R Adv Genet; 2010; 70():101-41. PubMed ID: 20920747 [TBL] [Abstract][Full Text] [Related]
12. Molecular Pathways: Metabolic Control of Histone Methylation and Gene Expression in Cancer. Tran TQ; Lowman XH; Kong M Clin Cancer Res; 2017 Aug; 23(15):4004-4009. PubMed ID: 28404599 [TBL] [Abstract][Full Text] [Related]
13. Challenges and Opportunities in Social Epigenomics and Cancer. Banaudha K; Kumar V; Verma M Methods Mol Biol; 2018; 1856():233-243. PubMed ID: 30178255 [TBL] [Abstract][Full Text] [Related]
14. Cancer: an epigenetic landscape. Dhanasekaran K; Arif M; Kundu TK Subcell Biochem; 2013; 61():399-417. PubMed ID: 23150260 [No Abstract] [Full Text] [Related]
15. Effect of non-enzymatic glycosylation in the epigenetics of cancer. Rehman S; Aatif M; Rafi Z; Khan MY; Shahab U; Ahmad S; Farhan M Semin Cancer Biol; 2022 Aug; 83():543-555. PubMed ID: 33276090 [TBL] [Abstract][Full Text] [Related]
16. Histone Variant H3.3 Mutations in Defining the Chromatin Function in Mammals. Trovato M; Patil V; Gehre M; Noh KM Cells; 2020 Dec; 9(12):. PubMed ID: 33353064 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic mechanisms in gastric cancer. Gigek CO; Chen ES; Calcagno DQ; Wisnieski F; Burbano RR; Smith MA Epigenomics; 2012 Jun; 4(3):279-94. PubMed ID: 22690664 [TBL] [Abstract][Full Text] [Related]
18. The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: a review. Vahid F; Zand H; Nosrat-Mirshekarlou E; Najafi R; Hekmatdoost A Gene; 2015 May; 562(1):8-15. PubMed ID: 25701602 [TBL] [Abstract][Full Text] [Related]
19. In situ chromatin interactomics using a chemical bait and trap approach. Burton AJ; Haugbro M; Gates LA; Bagert JD; Allis CD; Muir TW Nat Chem; 2020 Jun; 12(6):520-527. PubMed ID: 32472103 [TBL] [Abstract][Full Text] [Related]